These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6822401)

  • 1. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.
    Arnaout MA; Dana N; Melamed J; Medicus R; Colten HR
    Immunology; 1983 Feb; 48(2):229-37. PubMed ID: 6822401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of monomeric IgG bearing covalently bound C3b with polymorphonuclear leucocytes.
    Malbran A; Frank MM; Fries LF
    Immunology; 1987 May; 61(1):15-20. PubMed ID: 2953672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
    Fries LF; Prince GM; Gaither TA; Frank MM
    J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
    Melamed J; Arnaout MA; Colten HR
    J Immunol; 1982 May; 128(5):2313-8. PubMed ID: 6801135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
    Mehta RL; Takahashi H; Rudick RA; Knutson DW
    J Immunol; 1986 Mar; 136(5):1765-71. PubMed ID: 2936811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymic assay of C3b receptor on intact cells and solubilized cells.
    Sim E; Sim RB
    Biochem J; 1983 Feb; 210(2):567-76. PubMed ID: 6222733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human monomeric C3b with its receptor (complement receptor type 1, CR1) on neutrophils. Evidence for negative cooperativity.
    Porteu F; Halbwachs-Mecarelli L
    J Biol Chem; 1988 Apr; 263(11):5091-7. PubMed ID: 2965698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    Arnaout MA; Melamed J; Tack BF; Colten HR
    J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor.
    Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP
    J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
    Jelezarova E; Luginbuehl A; Lutz HU
    J Biol Chem; 2003 Dec; 278(51):51806-12. PubMed ID: 14527961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of activated C3b component with complement effector].
    Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
    Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of soluble human 125I-labeled C3b, the third component of complement, after binding to human cells.
    Charriaut C; Barel M; Frade R
    Eur J Immunol; 1982 Apr; 12(4):289-94. PubMed ID: 6980121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
    Gerdes J; Naiem M; Mason DY; Stein H
    Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.